Dr. Taranejoo is a former scientist at Harvard Medical School, MIT, and Mayo Clinic, where he worked on advanced biomaterials, drug delivery systems, and pharmaceutical innovations. He has over a decade of R&D experience in pharmaceutical formulation and process development. He has served as a scientific advisor at ESLA White Lab, where he contributed his expertise to advance aging and longevity research.

As the Co-Founder and CSO of Infopeutic, Dr. Taranejoo leads the development of cutting-edge drug formulations and hormone-based therapies to address aging and age-related diseases.

As a previous scientist at Stanford University, Dr. Tondar has many years of experience in pharmaceutical research. His research career spans both academia and industry. He has worked at UCLA, Georgetown, Cedars Sinai Medical Center, Amgen, Bristol Myers Squibb, Merck, and early-stage startups. He also has served as a bioinformatics advisor to venture capital firms.

With his extensive bioinformatics background in drug target identification, drug design, and drug targeting, Dr. Tondar leads the AI pipelines while serving as a Co-Founder and CEO at Infopeutic.